These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 14572332)

  • 21. A study on interferon-gamma (IFN-gamma) response by T cells stimulated by hepatitis B virus core antigen.
    Paul S; Tabassum S; Islam MN
    Bangladesh Med Res Counc Bull; 2004 Apr; 30(1):9-15. PubMed ID: 15376464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70.
    Peng M; Chen M; Ling N; Xu H; Qing Y; Ren H
    Vaccine; 2006 Feb; 24(7):887-96. PubMed ID: 16446013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
    Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Induction of specific cytotoxic T lymphocyte response against hepatitis B virus by hepatitis B virus S gene-modified dendritic cells].
    Lei CL; Huang CH; Yang Z; Tang XP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):108-10. PubMed ID: 17653306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rescue of dendritic cells malfunction and loading with HBV proteins in patients with chronic hepatitis B in vitro].
    Duan XZ; Su HB; Chen J; Zhang AM; Hu JH; Wang HF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):328-30. PubMed ID: 20387476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
    Gu WY; Cao XS; Qiu GQ; Chen ZX; Sheng LX; Xie XB; He J; Cen JN; Shen HL
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3475-80. PubMed ID: 16686063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H-2 Kd-restricted hepatitis B virus-derived epitope whose specific CD8+ T lymphocytes can produce gamma interferon without cytotoxicity.
    Chen A; Wang L; Zhang J; Zou L; Jia Z; Zhou W; Wan Y; Wu Y
    J Virol; 2005 May; 79(9):5568-76. PubMed ID: 15827171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers.
    Xiong SQ; Lin BL; Gao X; Tang H; Wu CY
    Int Immunopharmacol; 2007 May; 7(5):578-87. PubMed ID: 17386405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phenotype and function of myeloid dendritic cells pulsed with hepatitis B virus antigens in patients with HBV-associated hepatocellular carcinoma].
    Qian S; Shi M; Zhang H; Zhang B; Xu DP; Wang FS
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):248-52. PubMed ID: 15854486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase.
    Wang S; Han Q; Zhang G; Zhang N; Li Z; Chen J; Lv Y; Li N; Xing F; Tian N; Zhu Q; Liu Z
    Int Immunopharmacol; 2011 Apr; 11(4):406-11. PubMed ID: 21182997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
    Kawabuchi Y; Yamaguchi Y; Ohshita A; Minami K; Toge T
    Anticancer Res; 2004; 24(2C):1193-200. PubMed ID: 15154646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection.
    Feng IC; Koay LB; Sheu MJ; Kuo HT; Sun CS; Lee C; Chuang WL; Liao SK; Wang SL; Tang LY; Cheng CJ; Tsai SL
    J Biomed Sci; 2007 Jan; 14(1):43-57. PubMed ID: 17109186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
    Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
    J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between serum HBV DNA level and HBV-specific, nonspecific cytotoxic T lymphocytes and natural killer cells in patients with chronic hepatitis B.
    Gu XB; Yang XJ; Wang D; Hua Z; Xu YQ; Lu ZH
    Chin Med J (Engl); 2009 Sep; 122(18):2129-32. PubMed ID: 19781297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of stimulation of dendritic cell on HBV-epitopic cytotoxic T-lymphocyte].
    Zhang HH; He Y; Zhao H; Piao WH; Liu MC; Xi HL; Yu M; Wang GQ
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1171-6. PubMed ID: 16029590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HBcAg18-27 epitope fused to HIV-Tat 49-57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice.
    Wang S; Han Q; Zhang N; Chen J; Liu Z; Zhang G; Li Z
    Immunol Lett; 2010 Jan; 127(2):143-9. PubMed ID: 19883689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection.
    Paul S; Tabassum S; Islam MN
    Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):71-7. PubMed ID: 15813485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG.
    Song S; Wang Y; Zhang Y; Wang F; He Y; Ren D; Guo Y; Sun S
    Cancer Lett; 2007 Oct; 256(1):90-100. PubMed ID: 17656012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.